Read about research from the November 2023 ASCO Plenary Series, which explores emerging treatments for advanced myeloma and stomach and gastroesophageal junction cancers.
Research from the 2024 ASCO Genitourinary Cancers Symposium will highlight studies that explore treatments for kidney cancer and advanced prostate cancer.
In this podcast, 5 members of the Cancer.Net Editorial Board discuss new research and developments in the treatment of various genitourinary (GU) cancers including prostate cancer, bladder cancer, kidney cancer, and testicular cancer.
Research from the 2024 ASCO Gastrointestinal Cancers Symposium will highlight studies that explore treatment options for people with cancers of the gastrointestinal tract, such as colorectal cancer, esophageal cancer, liver cancer, and neuroendocrine tumors.
Stage IV lung cancer survivor Lindi Campbell shares what it was like being diagnosed with advanced disease, how a new treatment has helped her live longer, and why she chose to dedicate her work toward ending the stigma around lung cancer.
In this podcast, Dr. Richard L. Schilsky describes ASCO’s Targeted Agent and Profiling Utilization Registry (TAPUR) Study and what has been learned since it launched in 2016.
Read about 2 studies from the November 2023 ASCO Plenary Series, which explore emerging treatments for advanced cancers of the stomach and esophagus.
In this podcast, 3 members of the Cancer.Net Editorial Board discuss new research presented at the 2023 ASCO Annual Meeting in non-small cell lung cancer, small cell lung cancer, and mesothelioma.
In this podcast, 3 Cancer.Net Associate Editors discuss new research presented at the 2023 ASCO Annual Meeting in breast cancer, lymphoma, multiple myeloma, brain tumors, and von Hippel-Lindau syndrome.
Read research from the July 2023 session of the ASCO Plenary Series, which highlights a study evaluating a potential maintenance therapy option for people with advanced or recurrent TP53 wild-type endometrial cancer.
